What is the pathophysiology of tetanus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Tetanus

Tetanus results from tetanospasmin, a powerful neurotoxin produced by Clostridium tetani that irreversibly binds to neural tissue and blocks the release of inhibitory neurotransmitters (GABA and glycine), causing uncontrolled muscle rigidity and spasms. 1

Causative Organism and Entry

  • Clostridium tetani is a ubiquitous, spore-forming, motile Gram-positive anaerobic bacillus found in high concentrations in soil and animal excrement. 2, 1
  • Spores enter the body through breaches in the skin or mucous membranes, including puncture wounds, lacerations, burns, surgical sites, and umbilical stumps in neonates. 2, 1
  • The disease is noncommunicable—direct person-to-person transmission does not occur. 2

Germination and Toxin Production

  • Germination of spores occurs only under anaerobic conditions, such as in necrotic tissue resulting from deep puncture wounds or blunt trauma. 2, 1
  • Once germinated, the vegetative bacilli multiply and produce tetanospasmin, a potent exotoxin. 2, 1
  • Tetanospasmin is one of the most powerful biological toxins known. 3, 4

Toxin Mechanism and Neural Effects

  • Tetanospasmin binds irreversibly to neural tissue, which is the critical pathophysiologic feature explaining why treatment focuses on neutralizing circulating toxin before binding rather than reversing already-bound toxin. 1
  • The toxin enters the general circulation, binds to peripheral motor neurons and sensory neurons, and is transported retroaxonally to the spinal cord. 5
  • Once in the central nervous system, tetanospasmin enters inhibitory interneurons and prevents the release of inhibitory neurotransmitters (GABA and glycine) in the spinal cord, brainstem motor nuclei, and brain. 1, 5
  • This blockade of inhibitory neurotransmission produces unopposed excitatory signals, resulting in muscle rigidity and tonic spasms of skeletal muscles. 1, 3

Clinical Progression and Temporal Factors

  • The incubation period varies from 3 to 21 days (median: 7 days), with extremes of 1 day to several months depending on wound severity and distance from the central nervous system. 2, 1, 6
  • Shorter incubation periods are associated with more severe disease and poorer prognosis, as injuries closer to the central nervous system allow faster toxin transport. 2, 6
  • Generalized tetanus typically presents with trismus (lockjaw), followed by generalized rigidity caused by painful contractions of skeletal muscles that can impair respiratory function. 2

Life-Threatening Complications

  • Glottic spasm, respiratory failure, and autonomic instability (dysautonomia) can result in death. 2
  • The syndrome of sympathetic nervous system overactivity is a serious late complication. 3
  • The case-fatality ratio can be as high as 100% without high-quality medical care, but remains approximately 10-20% even in modern healthcare facilities. 2, 1, 6
  • Mortality is highest in infants and the elderly. 2, 6

Important Clinical Pitfall

  • Tetanus infection does not confer natural immunity because the amount of toxin required to cause disease is insufficient to stimulate an immune response, so patients must complete a full primary immunization series after recovery. 6, 7

References

Guideline

Pathophysiology and Clinical Manifestations of Tetanus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tetanus: a review.

Critical care medicine, 1979

Research

Current concepts in the management of Clostridium tetani infection.

Expert review of anti-infective therapy, 2008

Guideline

Tetanus Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Respiratory Sequelae After Tetanus Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.